Resuscitation with blood products in patients with trauma-related haemorrhagic shock receiving prehospital care (RePHILL): a multicentre, open-label, randomised, controlled, phase 3 trial.
- Crombie, Nicholas
- Doughty, Heidi A
- Bishop, Jonathan R B
- Desai, Amisha
- Dixon, Emily F
- Hancox, James M
- Herbert, Mike J
- Leech, Caroline
- Lewis, Simon J
- Nash, Mark R
- Naumann, David N
- Slinn, Gemma
- Smith, Hazel
- Smith, Iain M
- Wale, Rebekah K
- Wilson, Alastair
- Ives, Natalie
- Perkins, Gavin D
DOIAbstract
BACKGROUND Time to treatment matters in traumatic haemorrhage but the optimal prehospital use of blood in major trauma remains uncertain. We investigated whether use of packed red blood cells (PRBC) and lyophilised plasma (LyoPlas) was superior to use of 0·9% sodium chloride for improving tissue perfusion and reducing mortality in trauma-related haemorrhagic shock. METHODS Resuscitation with pre-hospital blood products (RePHILL) is a multicentre, allocation concealed, open-label, parallel group, randomised, controlled, phase 3 trial done in four civilian prehospital critical care services in the UK. Adults (age ≥16 years) with trauma-related haemorrhagic shock and hypotension (defined as systolic blood pressure <90 mm Hg or absence...
Add to ORKG